Withings Pulse Wave Velocity and Blood Pressure Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03099954

Enrollment

300

Registered

2017-04-04

Start date

2017-01-19

Completion date

2017-10-31

Last updated

2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated Blood Pressure, Hypertension, Mental Stress, Sleep Disorders

Brief summary

Measure pulse wave velocity stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.

Detailed description

The study population will be an estimated 300 healthy adult subjects from the United States. This population will be approximately 150 men and 150 women. In order to obtain a relatively diverse age range of users (with varying levels of arterial stiffness), we hope to enroll participants across three age ranges entered in the Withings application by the user: 18-40 years, 41-60 years, and \> 60 years. These spots will be filled by those that satisfy the inclusion/exclusion criteria on a first come, first served basis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* User of a (1) Withings blood pressure cuff (2) Withings activity tracker and (3) Withings Body Cardio scale * User has measured their blood pressure at least once per week for the majority of weeks over the last three months.

Exclusion criteria

* Aortic artery disease * Peripheral vascular disease * Atrial fibrillation * Weight \> 396 lbs. * Pregnant women

Design outcomes

Primary

Measure	Time frame	Description
Measure pulse wave velocity (PWV) stability in relation to time of day, day of the week, physical activity, sleep quality, stress levels and blood pressure.	Subjects will be expected to participate for a total of 16 weeks.	The study population will be an estimated 300 healthy adult subjects from the United States who own a Withings blood pressure cuff, Withings activity tracker, and Withings Body Cardio scale and have measured their blood pressure at least once per week for the majority of weeks over the last three months.

Countries

United States

Outcome results